Shandong Sinoglory Health Food Co., Ltd (SHA:603182)
China · Delayed Price · Currency is CNY 13.07
-0.09 (-0.68%)
At close: Aug 24, 2026
SHA:603182 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 1,556 | 1,382 | 1,484 | 1,690 | 1,609 | 1,230 |
Other Revenue | 4.12 | 4.12 | 4.19 | 4.09 | 3.91 | 4.28 |
| 1,560 | 1,386 | 1,488 | 1,695 | 1,613 | 1,234 | |
Revenue Growth | 12.45% | -6.89% | -12.17% | 5.05% | 30.69% | 27.43% |
Cost of Revenue | 1,383 | 1,209 | 1,309 | 1,486 | 1,405 | 1,075 |
Gross Profit | 177.02 | 176.9 | 179.49 | 208.37 | 208.37 | 159.24 |
Selling, General & Admin | 43.04 | 41.15 | 41.52 | 42.62 | 38.25 | 32.91 |
Research & Development | 12.88 | 10.37 | 10.41 | 9.9 | 16.67 | 17.13 |
Other Operating Expenses | 4.44 | 4.98 | 4.61 | 6.3 | 8.45 | 5.14 |
Operating Expenses | 58.93 | 55.06 | 49.28 | 67.16 | 63.67 | 56.74 |
Operating Income | 118.09 | 121.84 | 130.21 | 141.21 | 144.69 | 102.5 |
Interest Expense | -0.32 | -0.32 | -0.63 | -1.56 | -3.18 | -3.98 |
Interest & Investment Income | 1.59 | 1.74 | 4.36 | 7.13 | 2.77 | 2.84 |
Currency Exchange Gain (Loss) | 1.38 | 1.38 | 5.66 | 1.88 | 6.98 | -2.31 |
Other Non Operating Income (Expenses) | -5.28 | -0.39 | -0.47 | -0.36 | -4.31 | -0.27 |
EBT Excluding Unusual Items | 115.46 | 124.25 | 139.13 | 148.31 | 146.96 | 98.77 |
Gain (Loss) on Sale of Investments | - | - | - | - | -9.25 | 0.53 |
Gain (Loss) on Sale of Assets | 0.37 | 0.11 | -0.01 | -0.92 | 0.03 | -0.99 |
Asset Writedown | 0.03 | -0.43 | -0.12 | -0.27 | -0.31 | - |
Other Unusual Items | 1.38 | 1.38 | 3.69 | 1.3 | 10.86 | 3.32 |
Pretax Income | 117.25 | 125.31 | 142.69 | 148.41 | 148.3 | 101.63 |
Income Tax Expense | 28.17 | 30.61 | 33.55 | 38.28 | 33.92 | 22.48 |
Net Income | 89.08 | 94.7 | 109.14 | 110.14 | 114.38 | 79.15 |
Net Income to Common | 89.08 | 94.7 | 109.14 | 110.14 | 114.38 | 79.15 |
Net Income Growth | -21.61% | -13.23% | -0.91% | -3.71% | 44.51% | 6.83% |
Shares Outstanding (Basic) | 165 | 163 | 165 | 164 | 133 | 124 |
Shares Outstanding (Diluted) | 165 | 163 | 165 | 164 | 133 | 124 |
Shares Change | -0.07% | -1.26% | 0.59% | 23.59% | 7.54% | 0.21% |
EPS (Basic) | 0.54 | 0.58 | 0.66 | 0.67 | 0.86 | 0.64 |
EPS (Diluted) | 0.54 | 0.58 | 0.66 | 0.67 | 0.86 | 0.64 |
EPS Growth | -21.56% | -12.12% | -1.49% | -22.09% | 34.38% | 6.67% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 98.4 | 24.62 | -85.73 | -117.45 | 63.88 | 9.64 |
Free Cash Flow Per Share | 0.60 | 0.15 | -0.52 | -0.71 | 0.48 | 0.08 |
Dividend Per Share | 0.500 | 0.500 | 0.100 | 0.400 | 0.300 | - |
Dividend Growth | 400.00% | 400.00% | -75.00% | 33.33% | - | - |
Gross Margin | 11.34% | 12.77% | 12.06% | 12.30% | 12.92% | 12.90% |
Operating Margin | 7.57% | 8.79% | 8.75% | 8.33% | 8.97% | 8.30% |
Profit Margin | 5.71% | 6.83% | 7.33% | 6.50% | 7.09% | 6.41% |
Free Cash Flow Margin | 6.31% | 1.78% | -5.76% | -6.93% | 3.96% | 0.78% |
EBITDA | 188.04 | 192.25 | 163.32 | 175.63 | 178.26 | 130.27 |
EBITDA Margin | 12.05% | 13.87% | 10.97% | 10.36% | 11.05% | 10.55% |
D&A For EBITDA | 69.96 | 70.41 | 33.11 | 34.42 | 33.57 | 27.78 |
EBIT | 118.09 | 121.84 | 130.21 | 141.21 | 144.69 | 102.5 |
EBIT Margin | 7.57% | 8.79% | 8.75% | 8.33% | 8.97% | 8.30% |
Effective Tax Rate | 24.03% | 24.43% | 23.52% | 25.79% | 22.87% | 22.12% |
Revenue as Reported | 1,386 | 1,386 | 1,488 | 1,695 | 1,613 | 1,234 |
Advertising Expenses | - | 1.87 | 0.48 | 0.35 | 0.23 | 0.11 |